TimesSquare Capital Management's "U.S. Small Cap Growth Strategy" saw a 5.77% return in Q1 2024, outperforming the Russell 2000 Growth Index. Highlighting Krystal Biotech, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin
